Lenoss Oversubscribes $4 Million Series A Financing
Funding will accelerate commercialization, expand clinical evidence, and fuel…
Slater Invests in Octagon Therapeutics Seed Round
Octagon is developing new medicines for autoimmune disease based on selective…
Bolden Announces $1.5M Pre-Seed Financing
Development of Antisense Oligonucleotides Seeks to Promote Neurogenesis…
MindImmune Appoints Industry Leaders to Board
Brad Margus and Robert Michael Poole, MD FACP, bring deep background and…
Rhode Island Commerce Awards Slater $12M for Venture Development
VC Firm Receives SSBCI Funding for Second Time Providence, R.I. – In…
Slater Invests in XM Therapeutics from Brown University
Biotech Targeting Heart Failure and Pulmonary Fibrosis Comes out of Stealth…
RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company
New Fund Participates in Series A Financing for URI-Based MindImmune, Developer…
Noted Scientist Nancy Ryan Gray and Brown University Engineering Dean Lawrence Larson Join the Slater Board
New Appointees Bring Critical Insight into the Commercialization of…
RightHill Ventures Launches to Accelerate the Journey from Research to Startup for University Innovations
Beginning with Innovations from Brown University Researchers, New Fund Will…
Arctura Awarded $1.15 Million Grant from U.S. Dept. of Energy
SBIR Phase IIB Grant Will Enable Arctura to Field Test Its Proprietary…